Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition
about
Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.The impact of type 2 diabetes and antidiabetic drugs on cancer cell growthAdding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report.Nuclear receptors and pathogenesis of pancreatic cancer.Peroxisome proliferator-activated receptors and cancer: challenges and opportunitiesInhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE2Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells.The role of peroxisome proliferator-activated receptors in colorectal cancer.Human adipose-derived stem cell adipogenesis induces paracrine regulation of the invasive ability of MCF-7 human breast cancer cells in vitro.Rosiglitazone amplifies the sensitivity of docetaxel and reduces the expression of CD44v6.A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia.Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicityPPAR gamma, bioactive lipids, and cancer progression.A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.Peroxisome proliferator-activated receptor gamma and regulations by the ubiquitin-proteasome system in pancreatic cancerCorrelation between TSP-1, TGF-β and PPAR-γ expression levels and glioma microvascular density.
P2860
Q33692555-18DF1C32-F6AA-4134-A94A-48C06FABBBE9Q34095570-42B85C30-627A-4271-B5A8-2550D686F2ADQ34142424-C7C62217-4EBF-4C42-B781-6ABCC7E9B05FQ34168476-9F2AD670-1847-4A00-96B6-2EC671F48738Q35210023-BD04A727-6638-4CBC-8978-BA9F78A8C7A7Q35907145-C1A8160F-E91B-4F58-98E8-286C01F9BE1DQ36059702-DD9910BE-97F2-4897-9BD8-F11A0C4CAD3FQ36248494-21B9989E-EF51-49EF-A0D9-103FFECEAA37Q37231266-19DC2811-051C-4365-B8A7-A4FDE3A62443Q37652629-47EE8E9A-E209-4247-97AE-56FBEA093459Q37683288-DDC9EED7-8A49-401E-82DF-B8C64A2EFDDDQ37728667-770A7FF0-9E90-49A0-8ED3-1A5CAF150F28Q37971590-48952983-5A98-43E8-9FD3-C6405FABF45FQ38885892-39FC7A70-C7A6-44D0-A83B-F71894FF8AAAQ42098281-82E09C31-6BD7-44E3-B8C6-0B3A3B1B5B6CQ42801338-1BED6537-2E9A-42BB-BC36-84281B374E52
P2860
Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Suppression of pancreatic carc ...... volves angiogenesis inhibition
@en
Suppression of pancreatic carc ...... olves angiogenesis inhibition.
@nl
type
label
Suppression of pancreatic carc ...... volves angiogenesis inhibition
@en
Suppression of pancreatic carc ...... olves angiogenesis inhibition.
@nl
prefLabel
Suppression of pancreatic carc ...... volves angiogenesis inhibition
@en
Suppression of pancreatic carc ...... olves angiogenesis inhibition.
@nl
P2093
P2860
P356
P1476
Suppression of pancreatic carc ...... volves angiogenesis inhibition
@en
P2093
Xing-Peng Wang
Yu-Wei Dong
P2860
P304
P356
10.3748/WJG.15.441
P407
P577
2009-01-01T00:00:00Z